MKNK2 and neoplasm: In this study we show that manipulation of MKNK2 alternative splicing, elevating Mnk2a levels, inhibited survival and anchorage-independent growth of several cancer cell lines, sensitized glioblastoma cells to chemotherapy and inhibited glioblastoma tumor growth in vivo.